|
|
|
Antitrust/Competition
Tim Frazer represents and advises clients in a range of competition issues including merger, transactional, and conduct cases. He has obtained merger clearance at the European Commission (EC) and national competition authorities for complex cases requiring econometric evidence and Phase 1 disposals, such as Kraft Foods' hostile bid for Cadbury plc and Kraft Foods/Danone. He has advised clients in price-fixing and other conduct cases in various jurisdictions worldwide. He has designed and implemented on-line competition compliance programmes and audits for international companies. His practice includes advising leading consumer products and pharmaceutical companies on distribution systems, procurement, parallel trade, abuse, and other conduct issues. He divides his time between the firm's London and Brussels offices.
Tim has advised clients in the food, tobacco, chemicals, pharmaceuticals, medical devices, and consumer products industries, representing them before the UK Office of Fair Trading, the UK Competition Commission, and the European Commission.
He has authored several books on competition law, including Enterprise Act 2002, The Competition Act 1998, Competition Law and Policy, and Monopoly Competition and the Law, as well as many articles on competition law and theory.
Tim was previously a Professor and Dean of Law at Newcastle University.
Antitrust/Competition Representative Matters
- Advised Genzyme in relation to the $20.1 billion hostile bid by Sanofi-aventis
- Advised Kraft Foods on its hostile bid for Cadbury plc and on the disposal of certain businesses required by the EC
- Advised Kraft Foods International on its purchase of the global biscuits business of Danone, and on the disposal of certain brands required by the EC
- Advised Philip Morris International in clearing its acquisition of Papastratos at the EC
- Advised Kraft Foods International in clearing its acquisition of United Biscuits business in Spain and Portugal, at the EC
- Advised IPC Media PLC in relation to conduct and acquisitions in the UK
- Advised Astellas Pharma on competition issues in Europe
- Advised the Association of British Pharmaceutical Industries and a number of leading pharmaceutical companies on the investigation by the Office of Fair Trading into drugs prices in the UK
- Advised Tate & Lyle PLC in relation to competition issues in Europe
- Advised Motorola on agreements and licences in Europe
- Advised eBay in relation to competition issues in Europe
- Advised Solvay UK on disposals in the UK
- Advised a number of leading pharmaceutical companies on acquisitions, co-marketing and co-promotion agreements, and supply-chain management issues in Europe
- Advised IHS (formerly Technical Indexes) on acquisitions and other competition issues in Europe
- Advised a media trade association on digital rights management issues in Europe
- Advised Genzyme in relation to the $20.1 billion hostile bid by Sanofi-aventis
- Advised Kraft Foods on its hostile bid for Cadbury plc and on the disposal of certain businesses required by the EC
- Advised Kraft Foods International on its purchase of the global biscuits business of Danone, and on the disposal of certain brands required by the EC
- Advised Philip Morris International in clearing its acquisition of Papastratos at the EC
- Advised Kraft Foods International in clearing its acquisition of United Biscuits business in Spain and Portugal, at the EC
- Advised IPC Media PLC in relation to conduct and acquisitions in the UK
- Advised Astellas Pharma on competition issues in Europe
- Advised the Association of British Pharmaceutical Industries and a number of leading pharmaceutical companies on the investigation by the Office of Fair Trading into drugs prices in the UK
- Advised Tate & Lyle PLC in relation to competition issues in Europe
- Advised Motorola on agreements and licences in Europe
- Advised eBay in relation to competition issues in Europe
- Advised Solvay UK on disposals in the UK
- Advised a number of leading pharmaceutical companies on acquisitions, co-marketing and co-promotion agreements, and supply-chain management issues in Europe
- Advised IHS (formerly Technical Indexes) on acquisitions and other competition issues in Europe
- Advised a media trade association on digital rights management issues in Europe
Chambers Global: The World's Leading Lawyers for Business 2013 for Competition/European Law: Non-contentious (UK)
Chambers UK: A Client's Guide to the UK Legal Profession 2012-2013 for Competition/European Law: Non-contentious
The Legal 500 UK 2012 - Recommended for EU and Competition
PLC Which lawyer? 2012 - Recommended for Life Sciences: Competition/Antitrust
Chambers Global: The World's Leading Lawyers for Business 2011-2012 for Competition/European Law (UK)
PLC Which lawyer? 2012 - Recommended for Competition/Antitrust: Non-contentious
The Legal 500 UK 2011 - Recommended for Corporate and Commercial - EU and Competition
PLC Which lawyer? Yearbook 2009 and 2011 - Recommended for Life Sciences: Competition/Antitrust
Chambers Europe: Europe’s Leading Lawyers for Business 2011 for Competition/European Law
The International Who's Who of Competition Lawyers 2011
The Legal 500 UK 2011 for TMT: Pharmaceuticals and Biotechnology
Professional Activity
-
Fellow, Royal Society of Arts
-
Visiting Professor, University of Newcastle, England
Tim Frazer and Susan Hinchliffe "How reliable are warranties?" (PDF: 241 kB) The In-House Lawyer Magazine March 2013
Tim Frazer and Susan Hinchliffe "Proposed changes to the EU merger control regime" (PDF: 226 kB) The In-House Lawyer Magazine, December 2012
Tim Frazer, Lincoln Tsang, Mark Gardner and Jacqueline Mulryne "Getting the Deal Through: Pharmaceutical Antitrust - United Kingdom" (PDF: 345 kB) Global Competition Review, 2011
Tim Frazer and Lincoln Tsang "Getting The Deal Through: Pharmaceutical Antitrust - United Kingdom" (PDF: 584 kB) Global Competition Review, 2010
Tim Frazer, Ian Kirby, Camilla Balleny and Mark Gardner "Getting The Deal Through: Intellectual Property & Antitrust - United Kingdom" (PDF: 119 kB) Global Competition Review, 2010
Tim Frazer and Lincoln Tsang "Getting The Deal Through: Pharmaceutical Antitrust - United Kingdom" (PDF: 189 kB) Global Competition Review, 2009
Tim Frazer, Luc Gyselen, Marleen Van Kerckhove, Asim Varma and Barbara H. Wootton "Getting The Deal Through: Pharmaceutical Antitrust" (PDF: 444 kB) Global Competition Review, 2008
Tim Frazer, Luc Gyselen and Frank Liss "Cartel Prosecution in the US and the EU - Recent Developments" (PDF: 136 kB) Practical Law Company's Cross-Border Competition Law Handbook 2007/2008, January 2008
William Baer, Tim Frazer, Luc Gyselen and Frank Liss "Cartel Prosecution in the US and the EU- Recent Developments" (PDF: 134 kB) Practical Law Company's Cross-Border Competition Law Handbook, 2006/2007
Susan Hinchliffe, Tim Frazer and Camilla Balleny "Getting The Deal Through: Intellectual Property & Antitrust - United Kingdom" (PDF: 301 kB) Global Competition Review, 2008
Luc Gyselen, Tim Frazer and Frank Liss "International Leniency Coordination" (PDF: 102 kB) The Antitrust Review of the Americas 2007, Global Competition Review, September 2006
William Baer and Tim Frazer "International Leniency Regimes: New Developments and Strategic Implications" (PDF: 227 kB) Corporate Counsel's International Adviser, 1 November 2005
Luc Gyselen, Tim Frazer and Frank Liss "International Leniency Regimes: New Developments and Their Strategic Implications" (PDF: 100 kB) The Antitrust Review of the Americas 2006, Global Competition Review, 2006
Ian Kirby and Tim Frazer "Parallel Trade - How to Protect Your Brand" (PDF: 107 kB) January/February 2002
"Competition Law and Procurement in the NHS- Recent Developments" (PDF: 420 kB) Sep 2011
"Legal Professional Privilege in EU Competition Proceedings Denied to In-House Lawyers: The Court of Justice Rules in Akzo Nobel Chemicals Ltd v. Commission" (PDF: 395 kB) Sep 2010
"Italian Torpedo" Fails to Sink Rubber Cartel Litigation in English Courts" (PDF: 431 kB) Aug 2010
"A Culture of Compliance: The Office of Fair Trading Issues Tough New Guidance on Disqualifying Company Directors" (PDF: 533 kB) Jul 2010
"Shorter Process and Fair Process- One Step Forward, Two Steps Back For the Office of Fair Trading" (PDF: 710 kB) May 2010
"How the Kraft/Cadbury Bid Cleared Despite a High Market Share" (PDF: 332 kB) Feb 2010
"The EC Pharmaceutical Sector Inquiry: Getting Real" (PDF: 307 kB) Jul 2009
"Private Enforcement of EC State Aid Law--EC's Revamped Notice on the Role of National Courts" (PDF: 266 kB) Mar 2009
"Germany Limits the Reach of its Merger Control Law but Introduces New Foreign Investment Supervision" (PDF: 268 kB) Feb 2009
"Private Label Brands, "Must-Have" Brands, and Impact on Retailer Buyer Power" (PDF: 371 kB) Feb 2009
"European Commission Endorses A More Economic-Based Approach" (PDF: 332 kB) Dec 2008
"New Notice Clarifies EU Commission's Approach to Remedies in Merger Cases" (PDF: 673 kB) Oct 2008
"Quota Schemes: The New Rules for Pharmaceutical Companies--The European Court rules on the Use of Quota Schemes by Dominant Pharmaceutical Companies" (PDF: 850 kB) Sep 2008
"The Glaxo/Boehringer Case - Court of Appeal's Most Recent Decision, 'For the Present'" (PDF: 273 kB) Feb 2008
"The Office of Fair Trading Releases its Report into the Distribution of Pharmaceuticals in the UK" (PDF: 251 kB) Dec 2007
"ECJ Decision in the Glaxo/Boehringer Case" (PDF: 215 kB) Apr 2007
"THE OFT's NEW APPROACH TO CASE SELECTION: How To Tell If The OFT Will Proceed With A Complaint" (PDF) Oct 2006
"Opinion of the Advocate General in the Glaxo Boehringer Case" (PDF: 164 kB) Apr 2006
"New EU Regulation on Technology Transfer Agreements" (PDF) Apr 2004
"Parallel Trade: Update - Kohlpharma" (PDF: 174 kB) Apr 2004
"Parallel Trade: Advisory - Pharmaceuticals" (PDF: 191 kB) Mar 2004
"Parallel Trade: Advisory - Pharmaceuticals" (PDF: 181 kB) Mar 2004
"Parallel Trade: Update - Pharmaceuticals" (PDF: 205 kB) Feb 2004
"Parallel Trade: Update - Pharmaceuticals" (PDF: 1.16 MB) Apr 2003
"Parallel Trade: Update - Pharmaceuticals" (PDF: 501 kB) Nov 2002